ALX Oncology Inc.
ALXO | NASDAQ
$1.63
-$0.03 (-1.81%)
Sep 22, 2026, 2:09 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.59 | -0.65 | -3.98 | -3.72 | -10.38 | -67.34 |
PEG Ratio | 0.02 | 0.02 | -0.17 | -0.08 | -0.17 | -1.48 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | 2.91K |
PB Ratio | 2.33 | 0.77 | 3.37 | 1.74 | 2.39 | 7.99 |
P/FCF Ratio | -0.72 | -0.71 | -4.86 | -5.06 | -11.86 | -89.63 |
P/OCF Ratio | -0.72 | -0.71 | -4.91 | -5.14 | -12.72 | -89.70 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | -3.24K |
Debt / Equity Ratio | 0.20 | 0.15 | 0.09 | 0.04 | 0 | n/a |
Quick Ratio | 2.07 | 7.26 | 5.24 | 9.57 | 24 | 70.28 |
Current Ratio | 2.07 | 7.26 | 5.24 | 9.57 | 24 | 70.28 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | 0 |
Interest Coverage | -64.93 | -82.40 | -108.80 | -535.45 | -6.43K | -53.84 |
Return on Equity | -391.42% | -118.69% | -84.76% | -46.87% | -22.99% | -10.64% |
Return on Assets | -172.23% | -91.25% | -66.30% | -40.29% | -21.95% | -10.49% |
Return on Invested Capital | -261.95% | -108.24% | -81.81% | -45.64% | -22.85% | -10.16% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | 9.05% |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | -3.87K% |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | -3.85K% |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | -3.69K% |
FCF Margin | n/a | n/a | n/a | n/a | n/a | -3.24K% |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | -3.68K% |
Add to Watchlist
Select watchlists to add or remove ALXO